Background : Levels of atherogenic lipoproteins achieved with statin therapy are highly
variable, but the consequence of this variability for cardiovascular disease risk is not well-…

Despite numerous publications and clinical trials, the results of treatment of recalcitrant chronic
plantar fasciitis with extracorporeal shockwave therapy (ESWT) still remain equivocal as …

Recent research has focused on the use of high-sensitivity C-reactive protein (hs-CRP), a
marker of inflammation, in the detection of patients at increased risk for cardiovascular disease…

Aims The effect of statins on risk of heart failure (HF) hospitalization and HF death remains
uncertain. We aimed to establish whether statins reduce major HF events. Methods and …

… Thorslund M, Parker M. Care of the elderly in the changing Swedish welfare state. In: …
Clarfield is Director of Geriatrics in the Ministry of Health, Jerusalem, and with the Division of …

Context.—Although cholesterol-reducing treatment has been shown to reduce fatal and
nonfatal coronary disease in patients with coronary heart disease (CHD), it is unknown whether …

Background Trials of statin therapy have had conflicting findings on the risk of development
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …

Background Elevated levels of C-reactive protein, even in the absence of hyperlipidemia, are
associated with an increased risk of coronary events. Statin therapy reduces the level of C-…

Background Inflammation is causally related to atherothrombosis. Treatment with canakinumab,
a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted …

Context The associations of low-density lipoprotein cholesterol (LDL-C), non–high-density
lipoprotein cholesterol (non–HDL-C), and apolipoprotein B (apoB) levels with the risk of …